Sir,
Corona virus disease 2019 (COVID-19) is the infectious disease caused by the most recently discovered coronavirus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China, in December 2019.[1] SARS-CoV-2 (COVID-19) was declared a pandemic by the World Health Organization on March 11, 2020. As of October 30, 2020, the cases of COVID-19 infection continue to soar worldwide with no peak in sight making total case tally standing at 81,37,119 including 5.82,649 active cases, 72,32,839 cured/discharged/migrated and 1,21,641 deaths, according to the Ministry of Health and Family Welfare.[2] In Bihar till October 20, total cases were 207823 including 1011 death. Case fatality rates vary among country and even in country. Case fatality rate was found lowest in Bihar (0.48%) in comparison to other states or national figure of 1.49%. Several studies showed that old age, male sex, and comorbidities such as hypertension and cardiovascular disease are strong risk factors for COVID-19-related hospitalization and mortality.[3,4] This study is aimed to delineate the clinical characteristics and evaluate the prevalence of underlying comorbidities in COVID-19 deceased patients in Bihar.
We conducted a retrospective study with descriptive research and sought information from the Ministry of Health and Family Welfare, Government of India and State health society of Bihar website, interaction with state health officer of Bihar.
We analyze all the patients expire due to COVID infection in Bihar till October 20, 2020. Total 1011 patients deceased in given period. We found maximum death in 41–60 years age group, while 13.55% of the deceased were <40 years and 40.65% were >60 years old. Age-wise deceased cases are shown in Table 1. Among the deceased, 80.81% were male, whereas 19.18% were female. Case fatality rate found as 0.48%, which is far less than the national figure of 1.49%. It was found highest in elderly patient (2.15%), followed by 0.8%, 0.14%, and 0.02% for the patient with the age group of 41–60, 20–40, and <20 years old, respectively. About 35.5% of the deceased patients had preexisting comorbidities, which was <50.5% of the national figure shown by other study.[5] Hypertension was found as the most common comorbidity (37%), followed by diabetes, cardiac disease, chronic kidney diseases, chronic obstructive airway disease (asthma and COPD), and cancer [Figure 1]. The strong point of this study is one of the largest cohorts of deceased due to COVID-19 infection. This study found the highest death in patient with age group of 41–60 years, although the case fatality rate was highest in elderly patient with age >60 years. The lower mortality in Bihar could be attributed to the lower elderly population, lesser comorbidity, different climate, poor hygiene, and regular bacille Calmette-Guérin vaccination, but all these factors need to prove from further study.
Table 1.
Characteristics of corona virus disease 2019 deceased patients
| Variable | Total cases (n=207,823) | Total death (n=1011) | Case fatality rate (0.48%) |
|---|---|---|---|
| Age (years) | |||
| 0-20 | 43,507 | 13 (1.28) | 0.02 |
| 21-40 | 87,797 | 124 (12.26) | 0.14 |
| 41-60 | 57,405 | 463 (45.79) | 0.80 |
| >60 | 19,114 | 411 (40.65) | 2.15 |
| Male | 123,258 | 817 (80.81) | 0.66 |
| Female | 84,565 | 194 (19.18) | 0.22 |
| Any one comorbidity | 359 (35.5) |
Number in bracket shows proportion
Figure 1.
Prevalence (%) of comorbidities in covid 19 deceased cases, CKD: Chronic Kidney disease, COAD: Chronic obstructive airway disease
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33. doi: 10.1056/NEJMoa2001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ministry of Health & Family Welfare, Government of India. [Last accessed on 2020 Oct 31]. Available from: https://www.mohfw.gov.in .
- 3.Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. doi: 10.1016/j.jcv.2020. Epub 2020 Apr 14. PMID: 32315817; PMCID: PMC7195434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020 May;94:91–95. doi: 10.1016/j.ijid.2020.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Majeed J, Ajmera P, Goyal RK. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement. Diabetes Res Clin Pract. 2020;167:108349. doi: 10.1016/j.diabres.2020.108349. [DOI] [PMC free article] [PubMed] [Google Scholar]